Asian Photovoltaic Industry Association: China's growing photovoltaic industry may become the preferred choice of the European and American markets
21.9.2022 11:06:13 CEST | news aktuell GmbH | Press release

(Frankfurt, Germany)
In recent years, China's photovoltaic industry has become an important player in the global photovoltaic industry. For the global market, the choice of China's PV supply chain is an extremely favorable move.
Insiders believe that the essence of building a community of human destiny can be summarized by "national interests and common prosperity". Countries across the world should deeply understand that their destinies are closely linked to each other, so as to promote mutually beneficial cooperation, give full play to their own advantages, jointly make a larger cooperation cake, and guarantee the right of all countries to pursue prosperity and development.
In recent years, in order to rapidly reduce the use of coal, Europe has been promoting new energy sources very rapidly, relying on natural gas, while vigorously developing wind and hydroelectric power generation.
With the outbreak of the Russia-Ukraine conflict and the impact of a series of sanctions, energy prices tend to be even more prone to rise and difficult to fall. Analysis points out that Russia’s completely cut off the gas supply may lead to the eurozone into a serious recession, and further aggravate the already high-level inflation. At the same time, with the coming of the cold winter, Europe demand of electricity increases, and most European countries currently have limited reserves of natural gas, the future is likely to introduce related "gas restrictions" measures. In the background of economic recession, inflation and power shortage, Europe is bound to strengthen the investment in photovoltaic and other new energy power facilities, especially the construction of household light storage systems.
Chinese PV exports have also encountered some difficulties. According to Bloomberg, U.S. Customs has detained as much as 3 GW of imported PV modules since June of this year; by the end of the year, as much as 9 to 12 GW of PV modules are expected to be blocked from entering the U.S. market. This suggests that the U.S. Uyghur Forced Labor Prevention Act (UFLPA) is having a significant impact on trade flows; disruptions in U.S. PV trade with China could slow the expansion of the U.S. renewable energy industry, according to the report.
The industry believes that the U.S. crackdown on Chinese PV is unnecessary. "For the United States, the development of photovoltaic industry is its top priority to achieve low-carbon energy transition, it is wise to choose the appropriate Chinese imports, "an industry source said.
As the economist Qiu Jin previously said: "We are not participating in a sports competition, only a gold medal for all to compete, we can make the common cake, the common fruit bigger. By working together hard, we will achieve a win-win situation."
Contact:
Rotraut Wittkowski
+4915224939858
Images

About news aktuell GmbH
news aktuell, a subsidiary of the Deutsche Presse-Agentur (dpa), provides companies, institutions and associations with effective access to both the media and consumers and supports the organizations in telling their stories easily and successfully. Utilizing the digital tools “ots” and “zimpel” PR content reaches all media formats, including classic print titles, wide-reach online portals or social networks. In addition, news aktuell publishes all of its clients' PR content on www.presseportal.de, one of Germany's widest-reaching PR portals. Thus, all relevant multipliers are reached worldwide, ranging from editors and digital influencers to specialist bloggers and interested consumers. Communications specialists from all over Germany rely on the expertise of the dpa subsidiary. news aktuell has been on the market since 1989 and employs over 135 people. The company is based in Hamburg. Further locations include Berlin, Frankfurt and Munich.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Vyoma awarded ESA data procurement contract for space-based data on small space debris24.2.2026 10:53:34 CET | Press release
(Munich, February 24th, 2026) Vyoma, a Munich-based company providing Space Domain Awareness (SDA) capabilities, has been selected as the winner of the ESA tender on ”Data Procurement for Space-Based Statistical Data on Small Space Debris Phase 1”, funded via ESA‘s Space Safety Programme (S2P). ESA’s Meteoroid And Space debris Terrestrial Environment Reference (MASTER) model provides a description of the space environment around Earth, supporting satellite designers, operators and others with risk assessments. Currently, there exists a significant temporal and spatial knowledge gap for observations of space debris with sizes smaller than the detection limit of ground-based sensors. Vyoma's Flamingo-1 satellite is ideally positioned to generate the image data ESA is seeking. Flying “in-situ” at an altitude of 510 km, Flamingo-1's instrument can monitor large volumes of space at once. This sensor detects objects at long and short distances and captures small and fast objects reliably, im
Medi-Globe Launches mAI Companion® — the World’s First Real Time AI Assistant for Pancreatic EUS, Co Developed with IHU Strasbourg —Now MDR CE Marked and Available for Clinical Use in Europe24.2.2026 10:00:00 CET | Press release
Rohrdorf (Achenmühle), Germany — February 24, 2026 — Medi-Globe today announced the launch of mAI Companion®, a real-time medical AI solution designed to assist physicians in detecting pancreatic lesions during endoscopic ultrasound (EUS) — addressing one of the deadliest and most difficult-to-detect cancers, where earlier identification can dramatically change patient outcomes.
Grünenthal licenses exclusive Australian rights to Qutenza® to Clinect24.2.2026 08:43:52 CET | Press release
Aachen, Germany & Victoria, Australia, 24 February 2026 – Grünenthal, a global leader in pain management and related diseases, and Clinect Pty Ltd ("Clinect"), an Australian based company focussed on supporting access to unique products, announced today that they have entered into a definitive agreement whereby Clinect will have the exclusive Australian rights to Qutenza®, a topical, non-systemic, non-opioid patch indicated for the management of peripheral neuropathic pain. Under the agreement, Clinect will be responsible for obtaining marketing authorisation for Qutenza® in Australia and, upon approval, marketing and distributing the product in Australia.
Clean energy needs a clean planet: PLAN-B NET ZERO and everwave launch joint initiative20.2.2026 13:26:02 CET | Press release
(Berlin, Germany) A strong start to 2026. PLAN-B NET ZERO enters into a partnership with the Aachen-based environmental scale-up everwave. With the guiding principle ‘1 euro = 1 kilogram of waste’, the partners recovered 10,000 kilograms of waste from rivers in Cambodia at the start of the initiative Around 11 million tonnes of plastic waste enter the oceans every year. Without effective countermeasures, this volume could almost triple by 2040. Studies show that about 80 percent of marine plastic reaches the sea via roughly 1,656 rivers worldwide. To date, everwave has removed more than 2.4 million kilograms of plastic from rivers in Cambodia, Albania, and Thailand. The company uses waste collection boats, barriers, and manual cleanups to stop plastic before it reaches the oceans. At the same time, mobile sorting and recycling solutions return materials efficiently to the circular economy. AI support optimizes collection routes to clean as many waterways as possible in a sustainable wa
Grünenthal’s proprietary NaV 1.8 inhibitor enters clinical development18.2.2026 11:52:51 CET | Press release
Aachen, Germany, 18 February 2026 – Grünenthal announced today that the first healthy volunteers have been enrolled in a Phase I trial of its voltage-gated sodium channel (NaV) 1.8 inhibitor. The orally administered investigational medicine aims to provide a non-opioid therapy option across a range of acute and chronic pain conditions. Full results of the trial are expected in the second half of 2026.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
